FDA schedules a 1/11 online Grand Rounds on ethnicity- and gender-related differences in Alzheimers disease.
iTeos Therapeutics regains exclusive worldwide rights from Pfizer to develop EOS200271, a highly selective, clinical-stage indoleamine 2,3-dioxygenase...
Federal Register notice: FDA classifies the cervical intraepithelial neoplasia (CIN) test system into Class 2 (special controls).
FDA clears a Cerebrotech Medical Systems 510(k) for the Cerebrotech Visor, previously known as the CMS-5000 Intracranial Fluids Monitor.
A Health Affairs article heaps praise on FDA commissioner Scott Gottlieb in a review of agency accomplishments last year.
FDA clears a Cerebrotech Medical Systems 510(k) for the Cerebrotech Visor, previously known as the CMS-5000 Intracranial Fluids Monitor.
Federal Register notice: FDA makes available a draft guidance on Labeling for Combined Hormonal Contraceptives.
Federal Register notice: FDA announces a 3/23 Pediatric Advisory Committee meeting.